Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Herpes. Vaccines for HSV

L R Stanberry1

  • 1University of Cincinnati College of Medicine, Ohio, USA.

Dermatologic Clinics
|January 19, 1999
PubMed
Summary

Developing vaccines against herpes simplex viruses (HSV-1 and HSV-2) is crucial for preventing infections. This review covers past and current vaccine development strategies for both prevention and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens.

Vaccine·2011
Same author

The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.

Sexually transmitted infections·2006
Same author

Gender-specific predictors of genital herpes vaccine acceptance in a college population.

International journal of STD & AIDS·2005
Same author

Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?

Antiviral research·2004
Same author

Lessons from HIV and hepatitis viruses.

Antiviral research·2004
Same author

HSV shedding.

Antiviral research·2004

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Herpes simplex viruses (HSV-1 and HSV-2) are widespread human pathogens causing diverse clinical manifestations.
  • These infections range from oral-facial and genital herpes to severe conditions like neonatal herpes and herpes encephalitis.
  • The lifelong persistence of HSV necessitates effective prevention and treatment strategies.

Purpose of the Study:

  • To review historical and contemporary research on prophylactic and therapeutic vaccines against HSV.
  • To provide an overview of the challenges and progress in HSV vaccine development.

Main Methods:

  • Literature review of published studies on HSV vaccine development.
  • Analysis of preclinical and clinical trial data for various vaccine candidates.
  • Synthesis of information on different vaccine platforms and strategies.

Main Results:

  • Numerous vaccine candidates targeting HSV have been investigated over several decades.
  • Progress has been made in understanding HSV immunobiology, informing vaccine design.
  • Challenges remain in achieving high efficacy for both prophylactic and therapeutic vaccines.

Conclusions:

  • Despite extensive research, a universally effective HSV vaccine is yet to be developed.
  • Continued innovation in vaccine technology and a deeper understanding of HSV pathogenesis are essential.
  • Future efforts should focus on novel strategies to overcome existing hurdles in HSV vaccine development.

Related Experiment Videos